GSK3B and urinary bladder cancer: It is shown that GSK-3β inhibition leads to apoptosis via p53 activation in p53-wt HCT116 colon cancer cells (Tan et al., 2005) and a RT4 bladder cancer cell line (Kuroki et al., 2019).